Regenecure

Regenerative Polymeric Membrane for Bone Reconstruction

Health Tech & Life Sciences
Non Active, Jul 2016
Seed Jerusalem, Israel Founded 2010
Last updated 2026-06-18
Total raised
$3.5M
Last:
Stage
Seed
Founded
2010
Headcount
6
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Regenecure is dedicated to developing and marketing solutions for bone reconstruction. The companys regenerative, biocompatible, polymeric membrane implants are made of microporous ammonio methacrylate copolymer type A and a plasticizer. The microporous surface of the membrane facilitates the adherence of stem cells (MSCs) recruited to the injured site through a signaling mechanism known as chemotaxis. The membrane allows excellent proliferation and differentiation of MSCs into the bone tissue. The membrane implant is strong and flexible, and serves as an effective barrier to prevent connective tissue from infiltrating the healing space and slowing the regenerative healing process. Regenecures implant can be shaped into a tube or a patch to span large, segmental bone defects. The osteoconductive and osteoinductive qualities of the membrane ensure that Regenecures MSC scaffolding method directs bone in-growth naturally into the tubular implant. The membrane implant operates as a delivery system for cells and as a device for guided bone regeneration or tissue engineering purposes. It can also be used to deliver active agents such as osteoinductive agents, antiseptic agents, and more.

Funding history · 1 round · $3.5M total

Date unknown
$3.5M

Q&A

What is Regenecure's primary focus?
Regenecure is dedicated to developing and marketing solutions for bone reconstruction, specifically regenerative polymeric membrane implants.
What is the status of Regenecure?
Regenecure is currently inactive, with its status changed in July 2016.
When was Regenecure founded?
Regenecure was founded in May 2010.
How much funding has Regenecure raised in total?
Regenecure has raised a total of $3,500,000.
What is Regenecure's employee count?
Regenecure has 1-10 employees.
What is the primary sector of Regenecure?
Regenecure's primary sector is Health Tech & Life Sciences.
Where is Regenecure headquartered?
Regenecure is headquartered in Jerusalem, Jerusalem District, Israel.
Does Regenecure hold any patents?
Yes, Regenecure holds 1 patent.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & SubstancesImplantsPolymers
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesBiotechnology
Business model
B2B

Highlights

1 Patents

Tags

medical-technologiesregenerative-medicinetissue-regenerationorthopedicspolymersadherencestem-cellsbiomaterialscell-therapybonedoctorshospitals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)